LINC01506

Across TCGA pan-cancer cohorts, LINC01506 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of LINC01506’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where LINC01506 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01506 is over-expressed in tumor, although a few such as KICH and KIRP show the opposite, repressed pattern.

KICH, KIRP, and LUAD are the cancer types where LINC01506 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01506 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	III,IV	−1.747	<.001	11	view →
KIRP	All	III,IV	−1.069	<.001	11	view →
LUAD	Male	III,IV	−1.635	<.001	9	view →
LUSC	Female	All	−1.337	<.001	8	view →
BRCA	All	II,III,IV	−0.292	<.001	6	view →
KIRC	Male	All	−0.458	.001	4	view →
THCA	All	III,IV	+0.228	.003	3	view →
ESCA	All	All	+0.727	.023	1	view →
HNSC	Female	IV	+0.133	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

LINC01506–KICH

Open the KICH breakdown →